Role of p53 in the Regulation of Cellular Senescence
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
The p53 transcription factor plays a critical role in cellular responses to stress. Its activation in response to DNA damage leads to cell growth arrest, allowing for DNA repair, or directs cellular senescence or apoptosis, thereby maintaining genome integrity. Senescence is a permanent cell-cycle arrest that has a crucial role in aging, and it also represents a robust physiological antitumor response, which counteracts oncogenic insults. In addition, senescent cells can also negatively impact the surrounding tissue microenvironment and the neighboring cells by secreting pro-inflammatory cytokines, ultimately triggering tissue dysfunction and/or unfavorable outcomes. This review focuses on the characteristics of senescence and on the recent advances in the contribution of p53 to cellular senescence. Moreover, we also discuss the p53-mediated regulation of several pathophysiological microenvironments that could be associated with senescence and its development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Induction and initiation of cellular growth control and senescence via p53 or P16INK4A pathways. Various internal or external stress factors trigger the DNA-damage response (DDR) pathway, which in turn activates the p53 and/or the p16INK4A pathways. p16INK4A inactivates Cdk4/6, results in accumulation of phosphorylated pRb, stops the regulation of E2F transcription factors, and drives cell cycle arrest or senescence. These stressors also trigger DNA damage (cellular responses to such damages are regulated by either ATM-Chk2 or ATR-Chk1 pathways) and transactivate p53 and p21CIP1. Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].](https://figures.cochat.ai/paper-figures/73d1c8e4b31243a49a8fdf24b567946a/role-of-p53-in-the-regulation-of-cellular-senescence-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Senescence is driven by the tumor-suppressor pathways p53-p21CIP1 and p16INK4a-Rb,19,20,21”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“with CDKN2A (p16INK4a) and CDKN1A (p21CIP1) serving as canonical senescence markers.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
In the citing paper
“The p16INK4A/Rb pathway also plays a critical role in senescence. CDK4/6 are inactivated by p16INK4A, promoting the accumulation of phosphorylated Rb and the inactivation of E2F transcription, which induces senescence.66”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [66]
In the citing paper
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.85”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Cellular senescence is a physiological mechanism adopted by cells to limit tumorigenesis [99,100], and for this reason, a therapy-induced senescence was considered as an alternative and possibly safer approach to the traditional cancer therapy, which aimed at inducing extensive DNA damage [101].”
BackgroundInflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143 · cited 1×
“It is responsible for many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer [114,115].”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence is defined as a cell state characterized by prolonged and generally irreversible cell-cycle arrest [14] and the acquisition of different phenotypic alterations, including morphological changes, chromatin remodeling, metabolic reprogramming, and secretion of pro-inflammatory factors or SASP (senesce…”
BackgroundBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“This impressive number is a reflection of the many—sometimes alternative—roles p53 can play; in fact, several of these genes are known to be involved in the regulation of metabolism, autophagy, DNA damage repair, cell cycle arrest, quiescence, senescence, and apoptosis [35].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“However, once p16 is highly expressed, downregulation of p53 cannot reverse cell cycle arrest [58].”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Stressors include both intrinsic factors, such as oxidative damage, telomere attrition, hyperproliferation, oncogene activation, and environmental sources, including UV-light, γ-irradiation, and chemotherapeutic drugs [18,19].”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“They also reported co-localization of IL-8 and senescence markers in human colon adenomas [42].”
Background
Cited by
Items 101–200 of 640
Polat, I. H., Tarrado‐Castellarnau, M., Bharat, R., Perarnau, J., Benito, A., Cortés, R., Sabatier, P., & Cascante, M. (2021) · Biology · doi:10.3390/biology10020085 · Cited by 36
Bai, X., Ye, D., Shi, Y., Fan, M., Lü, P., Feng, Y., Hu, C., Liao, J., Cui, K., Tang, X., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.4.31 · Cited by 33
“71 Inactivation of p53 protects RGCs from diverse retinal damage such as ischemia.”
Cheng, Y., Zhang, M., Xu, R. H., Fu, L., Xue, M., Xu, C., Tang, C., Fang, T., Liu, X., Sun, B., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112391 · Cited by 31
“…is regarded as one of the most powerful tumor suppressor genes, and an increasing number of studies have shown that the activation of p53 may lead to tissue and organ aging and neurodegenerative diseases (Mijit et al., 2020; Tyner et al., 2002; Vigneron and Vousden, 2010; Vousden and Lane, 2007).”
BackgroundIs cellular senescence involved in cystic fibrosis?
Bezzerri, V., Piacenza, F., Caporelli, N., Malavolta, M., Provinciali, M., & Cipolli, M. (2019) · Respiratory Research · doi:10.1186/s12931-019-0993-2 · Cited by 34
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
“66 In addition, plasminogen activator inhibitor-1 (PAI-1), a p53 target gene, is a marker of senescence and is necessary for replicative senescence.”
Coughlan, M. T., Ziemann, M., Laskowski, A., Woodruff, T. M., & Tan, S. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-24851-w · Cited by 29
Phimnuan, P., Dirand, Z., Tissot, M., Worasakwutiphong, S., Sittichokechaiwut, A., Grandmottet, F., Viyoch, J., & Viennet, C. (2023) · ACS Omega · doi:10.1021/acsomega.2c07507 · Cited by 34
Thangavelu, L. P., Altamimi, A. S., Ghaboura, N., Babu, M. A., Roopashree, R., Sharma, P., Pal, P., Choudhary, C., Prasad, G. V. S., Sinha, A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155652 · Cited by 35
Wang, R.-R., Chen, D., Wei, M., Li, S.-R., Zhou, P., Sun, J., He, Q.-Y., Yang, J., Zhao, H., & Fu, L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103703 · Cited by 31
Tsai, C., Chang, C., Lin, B., Wu, Y., Wu, M., Lin, L., Huang, W., Holz, J. D., Sheu, T., Lee, J., et al. (2020) · Aging Cell · doi:10.1111/acel.13288 · Cited by 37
Ramírez, R., Ceprián, N., Figuer, A., Valera, G., Bodega, G., Alique, M., & Carracedo, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020215 · Cited by 31
“The same phenomenon was observed in animals of advanced age, with incr ased mol cu es a sociated with cellular senesc ce-like p53, p21, d p16 [28,29].”
BackgroundPost-GWAS functional analysis identifies CUX1 as a regulator of p16INK4a and cellular senescence
Jiang, D., Sun, W., Wu, T., Zou, M., Vasamsetti, S. B., Zhang, X., Zhao, Y., Phillippi, J. A., Sawalha, A. H., Tavakoli, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00177-0 · Cited by 31
Sriratanasak, N., Chunhacha, P., Zin, Z., & Chanvorachote, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112703 · Cited by 31
“p53 upregulates p21 levels, thereby inhibiting cyclin-dependent kinase (CDK) function, and cells undergo cell cycle arrest [14,15].”
BackgroundEscriche‐Navarro, B., Garrido, E. M. N., Sancenón, F., García‐Fernández, A., & Martínez‐Máñez, R. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.002 · Cited by 31
Cholesterol biosynthetic pathway induces cellular senescence through ERRα
Ziegler, D. V., Czarnecka‐Herok, J., Vernier, M., Scholtes, C., Camprubi, C., Huna, A., Massemin, A., Griveau, A., Machon, C., Guitton, J., et al. (2024) · npj Aging · doi:10.1038/s41514-023-00128-y · Cited by 35
“Dysfunctional mitochondria, ROS production, DNA damage and p53 mediate mevalonate pathway-induced senescence P53 is a well-known critical effector of cellular senescence 40 .”
BackgroundMulti-omics strategies to decode the molecular landscape of cellular senescence
Basilicata, M. G., Sommella, E., Scisciola, L., Tortorella, G., Malavolta, M., Giordani, C., Barbieri, M., Campiglia, P., & Paolisso, G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102824 · Cited by 31
“The senescence response functions as a protective barrier, primarily orchestrated by the p53/p21 and p16^INK4a^/Rb signaling pathways, which enforce cell cycle arrest and preserve genomic stability (Mijit et al., 2020).”
Cáceres-Gutiérrez, R. E., Alfaro‐Mora, Y., Andonegui, M. A., Díaz‐Chávez, J., & Herrera, L. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.751367 · Cited by 28
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber, C., Grabbe, S., & Bros, M. (2023) · Biomolecules · doi:10.3390/biom13071085 · Cited by 30
D’Orazi, G. (2021) · Biomolecules · doi:10.3390/biom11020211 · Cited by 30
“[6] highlights the crucial role of senescence and of p53-induced senescence in physiological and pathological processes.”
BackgroundUnderstanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
“…trigger DNA damage, which trans-activates p53 and p21 CIP1 , by the action of either ATM-Chk2 or ATR-Chk1 pathway. p21 CIP1 activation, which is a downstream regulator of p53, leads to the inhibition of cyclin-dependent kinases 4/6 which has a role in G1 arrest and senescence promotion [53–55].”
BackgroundHaj, M., Frey, Y., Levon, A., Maliah, A., Ben-Yishay, T., Slutsky, R., Smoom, R., Tzfati, Y., Ben‐David, U., Levy, C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2419196122 · Cited by 26
“This suggests that the p53/ p21 Cip1/Waf1 axis might play a role in initiating the cell cycle arrest while p16 INK4A is required for maintenance of the senescence - associated growth arrest ( 61 ).”
Patel, S. A., Černý, J., Gerber, W. K., Ramanathan, M., Ediriwickrema, A., Tanenbaum, B., Hutchinson, L., Meng, X., Flahive, J., BARTON, B. A., et al. (2023) · eJHaem · doi:10.1002/jha2.791 · Cited by 29
The interplay between cell death and senescence in cancer
Shimizu, K., Inuzuka, H., & Tokunaga, F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.001 · Cited by 30
Lithium inhibits oxidative stress-induced neuronal senescence through miR-34a
Tüfekçi, K. U., Alural, B., Tarakcioglu, E., San, T., & Genç, Ş. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06430-w · Cited by 27
KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis
Guo, T., Han, X., He, J., Feng, J., Jing, J., Janečková, E., Lei, J., Ho, T., Xu, J., & Chai, Y. (2022) · eLife · doi:10.7554/elife.74595 · Cited by 27
“The tumor suppressor P53 plays prominent roles in regulating DNA damage response, including arresting cell growth for DNA repair, directing cellular senescence, and activating apoptosis (Mijit et al. 2020).”
BackgroundRole of low-dose radiation in senescence and aging: A beneficial perspective
Xu, J., Liu, D., Zhao, D., Jiang, X. M., Meng, X., Jiang, L., Meina, Y., Zhang, L., & Jiang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120644 · Cited by 32
Black Ginseng Ameliorates Cellular Senescence via p53-p21/p16 Pathway in Aged Mice
Lee, S., Lee, D., O’Connell, J. F., Egan, J. M., & Kim, Y. (2022) · Biology · doi:10.3390/biology11081108 · Cited by 26
“One of the conserved pathways of cellular growth arrest is governed by p53 and p21, which play key roles in the initiation of senescence [42,43].”
Kaur, S., Pandit, K., Chandel, M., & Kaur, S. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-08916-9 · Cited by 24
“…in various cancer cell lines (Vijayababu et al. 2005; Zhang et al. 2012; Deng et al. 2013). p53 is a transcription factor that activates in response to DNA damage which led to cell growth arrest, allowing DNA repair and cellular apoptosis to maintain the integrity of genome (Mijit et al. 2020).”
BackgroundGarbacki, N., Willems, J., Neutelings, T., Lambert, C. A., Deroanne, C., Adrian, A., Franz, M., Maurer, M., Gieter, P. D., Nusgens, B., et al. (2023) · npj Microgravity · doi:10.1038/s41526-023-00339-3 · Cited by 26
The protective effect of PL 1-3 on D-galactose-induced aging mice
Li, P., Ma, Y., Wang, X., Li, X., Wang, X., Yang, J., & Liu, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1304801 · Cited by 25
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
“Phosphorylation, acting as a critical signal integrator within the ATM/ATR-p53-p21CIP1 and p16/Rb axes, coordinates SASP activation [100, 101].”
Teti, G., Chiarini, F., Mazzotti, E., Ruggeri, A., Carano, F., & Falconi, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111515 · Cited by 25
“Double strand DNA breaks promote the recruitment and binding of ATM kinase to the DNA damage site, which phosphorylates the histone H2AX, helping the assembly of specific DNA repair complex (Mijit et al., 2020; Hernandez-Seguira et al., 2018).”
InfluentialInvolvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
Barriuso, D., Alvarez-Frutos, L., Gutiérrez, L. G., Motiño, O., Kroemer, G., Palacios, R., & Senovilla, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076374 · Cited by 24
“The persistence of stressful stimuli over time results in the decline of p53/p21Waf1/Cip1, as opposed to an increase in the p16INK4a/retinoblastoma protein (pRb) [18].”
BackgroundXu, J.-Z., Zhou, Y.-M., Zhang, L.-L., Chen, X.-J., Yang, Y.-Y., Zhang, D., Zhu, K.-C., Kong, X.-K., Sun, L.-H., Tao, B., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01048-8 · Cited by 22
“To verify the aging bone microenvironment, we measured the expression of P16, P21, and P53, which were senescenceassociated genes [8, 23], and found that they were elevated in aged mice (Fig.”
Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy
Al-Arafat, T., Mao, A., Katsube, T., & Wang, B. (2024) · Radiation · doi:10.3390/radiation4040023 · Cited by 24
“It also enhances the transcription of genes that code for promyelocytic leukemia protein, further promoting the process of cellular senescence [40].”
Moselhy, O. A., Abdel-Aziz, N., El-Bahkery, A. M., Moselhy, S. S., & Ibrahim, E. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-87635-y · Cited by 28
Developmental Acquisition of p53 Functions
Jaiswal, S. K., Raj, S., & Depamphilis, M. (2021) · Genes · doi:10.3390/genes12111675 · Cited by 25
“These include maintaining genomic stability by inducing cell cycle arrest, apoptosis or senescence [19-21], regulating homeostasis and metabolism [22], regulating pluripotency and differentiation [23,24], triggering inflammation [25], reducing reproduction [26], regulating aging [27], and stimulating tissue regenerati…”
BackgroundYu, M.-H., Tsai, M., Wang, C., Wu, S., Chang, Y., Wu, C., & Wang, C. (2021) · Pharmaceuticals · doi:10.3390/ph14121310 · Cited by 23
“The tumor suppressor p53 is crucial to numerous cellular responses, to stress signals, and triggers responses such as senescence, apoptosis, and cell cycle arrest [27].”
BackgroundModulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease
Pedroza-Díaz, J., Arroyave-Ospina, J. C., Salas, S. S., & Moshage, H. J. (2022) · Antioxidants · doi:10.3390/antiox11050975 · Cited by 31
“Likewise, p53 levels can be stabilized and the maintenance of the senescence phenotype is often associated with p16 activation, when the senescent state is already stablished and it cannot be reversed by inhibiting p53 [32].”
BackgroundTakaya, K., Asou, T., & Kishi, K. (2022) · GeroScience · doi:10.1007/s11357-022-00648-7 · Cited by 24
“p53, another major suppressor, is upregulated in senescent cells [32], and CTSF may function similarly as a major suppressor in senescent cells in response to DNA damage.”
BackgroundCatalà, P., Gröen, N., LaPointe, V. L. S., & Dickman, M. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-36567-6 · Cited by 25
“P53 is a known senescence regulator (Mijit et al., 2020; Rufini et al., 2013), and its inhibition could delay the cellular senescence in primary CECs.”
BackgroundTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
“For the latter, telomere damage/shortening activates the p53/p19ARF and p16Ink4a/Rb signaling pathways, leading to cell senescence and proliferation arrest [120,121].”
Shi, L., Deng, J., He, J., Zhu, F., Jin, Y., Zhang, X., Ren, Y., & Du, X. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176632 · Cited by 25
ATM and p53 in aging and cancer: a double-edged sword in genomic integrity
Pandey, S. N., Afzal, M., Uikey, J., Ganesan, S., Mishra, S., Bansal, P., Kazmi, I. A., Alzarea, S. I., Almalk, W. H., Goyal, K., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10249-4 · Cited by 26
“It has been considered a promising therapeutic strategy (Mijit et al. 2020; Yang et al. 2024a).”
Ubiquilin Networking in Cancers
Jantrapirom, S., Piccolo, L. L., Pruksakorn, D., Potikanond, S., & Nimlamool, W. (2020) · Cancers · doi:10.3390/cancers12061586 · Cited by 22
“The tumor suppressor protein, p53 mediates various mechanisms to arrest cell cycle and allow DNA repairs or induce cell apoptosis due to an occurrence of unmanageable DNA damages [25].”
BackgroundCOVID-19, ferrosenescence and neurodegeneration, a mini-review
Sfera, A., Osorio, C. P., Maguire, G. A., Rahman, L., Jafri, A., Cummings, M. A., & Maldonado, J. C. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110230 · Cited by 25
Mohiuddin, M., & Kasahara, K. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20288 · Cited by 23
“Previous studies have suggested that the suppression of the p53/p21 and p16/pRb signaling pathways can inhibit cellular senescence (46-48).”
BackgroundKlabklai, P., Phetfong, J., Tangporncharoen, R., Isarankura‐Na‐Ayudhya, C., Tawonsawatruk, T., & Supokawej, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012521 · Cited by 21
“P53 plays a vital role in initiating cellular senescence by activation of the p53/p21 pathway, thereby resulting in cell cycle arrest [31].”
BackgroundProtein-Bound Uremic Toxins in Senescence and Kidney Fibrosis
Yang, Y., Mihajlovic, M., & Masereeuw, R. (2023) · Biomedicines · doi:10.3390/biomedicines11092408 · Cited by 24
Ma, Y., Wang, X., Li, X., Chen, X., Teng, Z., Wang, X., Yang, J., & Liu, G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03976-1 · Cited by 21
“According to reports, the SIRT1 deficiency can promote the expression of aging-related genes [39]. p53/p21 and p16/Rb pathways play the critical role in the aging process through cell cycle arrest [40, 41].”
BackgroundHuff, L. A., Yan, S., & Clemens, M. G. (2021) · Antioxidants · doi:10.3390/antiox10071146 · Cited by 23
Evidence of the Beneficial Effects of Ursolic Acid against Lung Cancer
Kornel, A., Nadile, M., & Tsiani, E. (2022) · Molecules · doi:10.3390/molecules27217466 · Cited by 24
Causes of Clonal Hematopoiesis: a Review
Joo, L., Bradley, C. C., Lin, S. H., Scheet, P. A., & Nead, K. T. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01362-z · Cited by 26
Senescence: a double-edged sword in beta-cell health and failure?
Varghese, S. S., & Dhawan, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196460 · Cited by 23
Shiwakoti, S., Adhikari, D., Lee, J. P., Kang, K., Lee, I., Kim, H. J., & Oak, M. (2020) · Antioxidants · doi:10.3390/antiox9121243 · Cited by 20
“The transcription factor p53 plays a critical role in cellular responses to these stresses, and its activation leads to cell growth arrest, allowing for DNA repair, or triggers cellular senescence [62].”
BackgroundLack of apoptosis leads to cellular senescence and tumorigenesis in Drosophila epithelial cells
Garcia-Arias, J. M., Pinal, N., Cristobal-Vargas, S., Estella, C., & Morata, G. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01583-y · Cited by 19
“Interactions with JNK Acute activation of p53 after cellular stress has been shown to be implicated in the acquisition of senescence in mammalian cells [49, 50], and also in Drosophila [34], but the mechanism by which p53 contributes to senescence in Drosophila has not been studied.”
BackgroundEmerging role and therapeutic implications of p53 in intervertebral disc degeneration
Wang, Y., Hu, S., Zhang, W., Zhang, B.-F., & Yang, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01730-5 · Cited by 22
“Once activated, p21 induces cell cycle arrest in the G1/S or G2/M phases by inhibiting apoptosis [286].”
BackgroundHaga, M., Iida, K., & Okada, M. (2024) · iScience · doi:10.1016/j.isci.2024.109708 · Cited by 19
“FC and adj-p were calculated using DESeq2. in the RNA-seq, differential ATAC peaks, and differential H3K27Ac peaks (Figure 1G) between PDL 24, PDL 36, and PDL 47.”
The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis
Zhang, X., Wang, J., Tang, K., Yang, Y., Liu, X., Yuan, S., Guo, F., Zhang, L., & Ma, K. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06721-7 · Cited by 28
“Further ACT experiments revealed that increased p16 expression in T cells signi fi cantly impaired their ability to mount an effective anti-tumor immune response by diminishing T cell persistence and promoting terminal exhaustion of tumor-in fi ltrating T cells in vivo.”
BackgroundHuman Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions
Chmielewski, P. P., Data, K., Strzelec, B., Farzaneh, M., Anbiyaiee, A., Zaheer, U., Uddin, S., Sheykhi-Sabzehpoush, M., Mozdziak, P. E., Zabel, M., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0280 · Cited by 37
Hugo, C., Asante, I., Sadybekov, A., Katritch, V., & Yassine, H. N. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0794 · Cited by 20
“Prostaglandin in fl ux activates Ras, leading to activation of p53, a major modulator of the senescence program (Mijit et al., 2020), which then promotes cell cycle arrest and the sequential upregulation of COX-2 to trigger the cascade of more oxylipin biosynthesis (Fig.”
Venkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
Cellular Senescence and Aging in Myotonic Dystrophy
Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042339 · Cited by 22
The functional role of cellular senescence during vascular calcification in chronic kidney disease
Fang, Y., Zhao, Y., Huang, J., Yang, X., Liu, Y., & Zhang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1330942 · Cited by 28
“The cell cycle arrest that characterizes cellular senescence is primarily governed by the p53/p21 and p16/RB pathways (44, 45).”
BackgroundCellular senescence: from homeostasis to pathological implications and therapeutic strategies
Li, C., Yuan, Y., Jia, Y., Zhou, Q., Wang, Q., & Jiang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1534263 · Cited by 29
Fernandez, B., Passanisi, V. J., Ashraf, H. M., & Spencer, S. L. (2025) · Nature Communications · doi:10.1038/s41467-025-66836-z · Cited by 18
Sato, K., Iwasaki, S., & Yoshino, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413233 · Cited by 19
“After DNA damage, p21 induces cell cycle arrest, leading to cellular senescence [30], while it mainly protects cells from apoptosis through the inhibition of apoptosis-inducing proteins [31].”
BackgroundHerrmann, J., Xia, M., Gummi, M. R., Greco, A., Schacke, A., van der Giet, M., Tölle, M., & Schuchardt, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.752305 · Cited by 22
Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest
Rossi, M. S., Anerillas, C., Idda, M. L., Munk, R. B., Shin, C. H., Donegà, S., Tsitsipatis, D., Herman, A. B., Martindale, J. L., Yang, X., et al. (2023) · eLife · doi:10.7554/elife.84238 · Cited by 17
“The p53 transcription factor is a key regulator of cellular stress responses and senescence by governing gene expression programs and suppressing cell proliferation (Mijit et al., 2020).”
BackgroundCurrent insights and future directions of Li-Fraumeni syndrome
Hosseini, M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01435-w · Cited by 20
Imran, S. A. M., Yazid, M. D., Idrus, R. B. H., Maarof, M., Nordin, A., Razali, R. A., & Lokanathan, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083888 · Cited by 20
“The function of p53 was shown to be significantly more important in preventing cancer in older organisms; a study found a higher incidence of tumors in mice at 12 months compared to mice at 3 months after p53 deletion [68].”
BackgroundTargeting cellular senescence to combat cancer and ageing
Wang, C., Hao, X., & Zhang, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13266 · Cited by 21
Jeske, R., Chen, X., Ma, S., Zeng, E. Z., Driscoll, T. P., & Li, Y. (2022) · Biochemical Engineering Journal · doi:10.1016/j.bej.2022.108711 · Cited by 22
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhang, Z., Liu, P., Song, Y., Ma, L., Xu, Y., Lei, J., Tong, B., Zhu, D., Liang, H., Wang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70417 · Cited by 26
“179 Among the numerous downstream effectors of p53, the protein p21 is particularly instrumental in driving cell senescence.”
Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
Soond, S. M., Savvateeva, L. V., Makarov, V. A., Gorokhovets, N. V., Townsend, P. A., & Zamyatnin, A. A. (2020) · Cancers · doi:10.3390/cancers12113476 · Cited by 18
“senescence and apoptotic death signaling pathways [6].”
BackgroundP53-Related Anticancer Activities of Drimia calcarata Bulb Extracts Against Lung Cancer
Laka, K., & Mbita, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.876213 · Cited by 18
“…natural compounds has been particularly successful in the field of anticancer drug research (Ashrafizadeh et al., 2020a; Ashrafizadeh et al., 2020b; Mirzaei et al., 2021; Abadi et al., GRAPHICAL ABSTRACT | Frontiers in Molecular Biosciences | www.frontiersin.org June 2022 | Volume 9 | Article…”
BackgroundGupta, P., Strange, K., Telange, R., Guo, A., Hatch, H. M., Sobh, A., Elie, J., Carter, A. M., Totenhagen, J. W., Tan, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111218 · Cited by 18
Banerjee, P., Gaddam, N., Pandita, T. K., & Chakraborty, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032877 · Cited by 21
“The telomeric erosion and the DNA damage response pathway leads to the activation of p53 [72,73].”
BackgroundThe Uremic Toxin Indoxyl Sulfate Accelerates Senescence in Kidney Proximal Tubule Cells
Yang, Y., Mihajlovic, M., Janssen, M. J., & Masereeuw, R. (2023) · Toxins · doi:10.3390/toxins15040242 · Cited by 20
“The p53/p21 pathway plays a key role in the initiation of senescence [45].”
Backgroundp‑Coumaric acid suppresses reactive oxygen species‑induced senescence in nucleus pulposus cells
Sheng, K., Li, Y., Wang, Z., Hang, K., & Ye, Z. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.11106 · Cited by 18
“p53 mainly functions as a transcription factor, regulating the expression of specific target genes (32).”
BackgroundMargier, M., Kuehnemann, C., Hulo, N., Morales, J. E., Kumaar, P. V. A., Cros, C. D., Cannelle, H., Charmetant, J., Verdin, E. M., Canault, M., et al. (2022) · Cells · doi:10.3390/cells12010108 · Cited by 18
Mandl, M., Wagner, S., Hatzmann, F. M., Ejaz, A., Ritthammer, H., Baumgarten, S., Viertler, H. P., Springer, J., Zwierzina, M., Mattesich, M., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa098 · Cited by 18
“Thus, according to the current models (47), the loss of the function of Sprouty1 might induce an early senescence phenotype in human ASCs in which the p16INK4A protein is absent and/or not yet expressed.”
BackgroundAuler, M. M. K., Bergmeier, V., Georgieva, V. S., Pitzler, L., Frie, C., Nüchel, J., Eckes, B., Hinz, B., & Brachvogel, B. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.11.011 · Cited by 20
Miller, S. J., Darji, R. Y., Walaieh, S., Lewis, J. A., & Logan, R. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1271941 · Cited by 16
“For example, in response to cellular stress, some senolytic secondary metabolites will activate either the intracellular p53 or P16 INK4A pathways, leading to a senescent cellular state (85).”
Gupta, S., Silveira, D. A., Mombach, J. C. M., & Hashimoto, R. F. (2025) · Proteomes · doi:10.3390/proteomes13010006 · Cited by 21
The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer
Balaraman, A. K., Afzal, M., Moglad, E. H. O., Babu, M. A., Priya, G. P., Bansal, P., Rajotiya, S., Kondapavuluri, B. K., Kazmi, I. A., Alzarea, S. I., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10194-2 · Cited by 16
“…parallel and often in cooperation. p53 responds to cellular stress signals, such as DNA damage and oxidative stress, by activating the transcription of p21, another CDK inhibitor (Mijit et al. 2020). p21 enforces cell cycle arrest by inhibiting CDK activity, complementing the effects of p16INK4a.”
Cellular Models of Aging and Senescence
Kim, B., Lee, D. I., Basisty, N., & Dai, D.-F. (2025) · Cells · doi:10.3390/cells14161278 · Cited by 16
“SIPS approaches are preferred when modeling acute stress responses or when standard protocols are incompatible with the cell type under study [59].”
Qing, Y., Li, H., Zhao, Y., Hu, P., Wang, X., Yu, X., Zhu, M., Wang, H., Wang, Z., Guo, Q., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5529518 · Cited by 19
Li, T., Lu, L., & Meng, Y. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666221025104629 · Cited by 16
In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells
Veronesi, F., Contartese, D., Sarno, L. D., Borsari, V., Fini, M., & Giavaresi, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115617 · Cited by 24
Zheng, L., Li, M., & Li, H. (2024) · Biomolecules · doi:10.3390/biom14030329 · Cited by 19
“The p53/p21 CIP1 pathway [23] is triggered by the ATM-CHK2/ATR-CHK1 (checkpoint kinase) pathway [24], which enhances the synthesis of the p21 CIP1 protein, leading to cellular senescence.”
BackgroundNadeem, J., Sultana, R., Parveen, A., & Kim, S. Y. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70046 · Cited by 21
Ding, F., Yu, Y., Zhao, J., Wei, S., Zhang, Y., Han, J. H., Li, Z., Jiang, H., Ryu, D., Cho, M., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1593096 · Cited by 19
“The DNA damage response (DDR), through activation of ATM/ATR kinases, leads to stabilization of the tumor suppressor p53, which in turn promotes the expression of cell cycle inhibitors such as p21 cip1 (Mijit et al., 2020).”
InfluentialWu, H., Zhang, Q., Zhu, J., Wu, L., Xiao, Y., & Yang, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.002 · Cited by 35
“The same key cell cycle regulatory pathways that initiate senescence, notably the p53-p21 axis, are also central regulators of apoptosis [34,35].”
Bioactive peptides in cosmetic formulations: Review of current in vitro and ex vivo evidence
van Walraven, N., Fitzgerald, R. J., Danneel, H.-J., & Amigo‐Benavent, M. (2025) · Peptides · doi:10.1016/j.peptides.2025.171440 · Cited by 20
Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells
Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.865811 · Cited by 16
Detection of Cellular Senescence in Human Primary Melanocytes and Malignant Melanoma Cells In Vitro
Zimmermann, T., Pommer, M., Kluge, V., Chiheb, C., Muehlich, S., & Bosserhoff, A. (2022) · Cells · doi:10.3390/cells11091489 · Cited by 31
VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis
Li, J., Huang, D., Lei, B., Huang, J., Yang, L., Nie, M., Su, S., Zhao, Q., & Wang, Y. (2022) · eLife · doi:10.7554/elife.83272 · Cited by 17
DREAM a little dREAM of DRM: Model organisms and conservation of DREAM‐like complexes
Hoareau, M., Rincheval‐Arnold, A., Gaumer, S., & Guénal, I. (2023) · BioEssays · doi:10.1002/bies.202300125 · Cited by 15
“[74,75] Interestingly, the senescence of conditionally immortalized human breast fibroblasts is associated to the down-regulation of numerous genes, of which respectively 49%, 16% and 22% are targets of DREAM, RB-E2F, and MMB-FOXM1.”
BackgroundChen, J., Li, G., He, X., Chen, Z., Chen, Z., Liu, D., Guo, S., Huang, T., Lan, P., Lan, P., et al. (2023) · Gastroenterology report · doi:10.1093/gastro/goae045 · Cited by 18
“For example, increased expression of p16 and p21 can inhibit the cell cycle, leading to cellular senescence [40, 41].”
Background
Metadata
- Authors
- Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A.
- Affiliations
- University of Siena (IT)
- Temple University (US)
- University of L'Aquila (IT)
- Corresponding author
- Giordano, Antonio
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-03-08
- Volume
- 10
- Issue
- 3
- Pages
- 420
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7175209
- OpenAlex
- W3010215457
- Cited by
- 639
- References
- 128
- Citations by year
- 2026: 100 · 2025: 142 · 2024: 126 · 2023: 96 · 2022: 92 · 2021: 64 · 2020: 17
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- TUScholarShare (Temple University) (submittedVersion, cc-by)
- UniTERAMO Research Catalog (University of Teramo) (submittedVersion, other-oa)
- Use Siena air (University of Siena) (submittedVersion, other-oa)
- Funders
- H2020 Marie Skłodowska-Curie Actions (713714)
- Commonwealth of Pennsylvania, Department of Health (290228/13650)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, DNA damage response, cell cycle arrest, apoptosis, genome stability, aging, antitumor immunity, senescence-associated secretory phenotype, inflammatory cytokines, tumor microenvironment, tissue dysfunction
- MeSH terms
- Animals, DNA Damage, DNA Repair, Humans, Tumor Suppressor Protein p53, Cellular Senescence, Cell Cycle Checkpoints, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.